MindMaze is a global neurotechnology company developing advanced digital therapeutics and AI-driven platforms for brain health, neurological recovery, and cognitive rehabilitation. Founded in Switzerland, MindMaze integrates neuroscience, artificial intelligence, virtual reality, and motion capture to deliver cutting-edge solutions that support recovery from stroke, traumatic brain injury, Parkinson’s disease, and other neurological conditions.
The company’s mission is to build the infrastructure for brain technology by creating medical-grade solutions that promote neuroplasticity and accelerate rehabilitation. MindMaze’s digital therapeutics are deployed in hospitals, clinics, and home settings worldwide, providing patients and clinicians with clinically validated tools that enhance engagement, improve outcomes, and reduce recovery time.
Features
MindMaze offers a suite of neurorehabilitation solutions based on digital therapeutics and motion-based interfaces. One of the core platforms is MindMotion™, a real-time motion capture system combined with gamified exercises that help patients perform therapy activities in an engaging, interactive environment.
MindMotion™ is available in different configurations for various recovery stages. MindMotion™ GO is designed for outpatient and home-based rehabilitation, while MindMotion™ PRO is used in acute care settings to initiate early intervention after brain injury or stroke.
The platform uses 3D motion tracking, neuroscience-based algorithms, and virtual reality interfaces to guide patients through therapeutic exercises. These exercises are personalized based on the patient’s motor and cognitive deficits, and the AI engine tracks progress over time, providing actionable insights to clinicians.
MindMaze also offers MaskEX, a VR platform focused on sensory-motor stimulation, and has invested in developing neuro-restorative platforms that support remote monitoring, patient engagement, and data-driven treatment planning.
A key differentiator is that MindMaze combines cognitive and motor rehabilitation in a single digital ecosystem, allowing for comprehensive recovery approaches across physical and mental health domains.
How It Works
MindMaze’s rehabilitation platforms use a combination of sensors, motion tracking cameras, and interactive software to deliver personalized therapy. Patients engage in VR-based exercises that simulate real-world activities, such as reaching, grasping, or balance control.
During each session, the system captures motion data and adjusts the difficulty level based on the patient’s performance. The AI-driven software provides real-time feedback, which helps patients correct movements and encourages continuous improvement.
For clinicians, the platform offers a secure dashboard with session analytics, performance trends, and therapy compliance reports. This data enables therapists to modify programs, measure recovery metrics, and make informed decisions.
MindMotion™ devices are designed to be portable and easy to set up, making them suitable for hospital use, outpatient clinics, or even patient homes. The systems require minimal infrastructure and are compliant with medical safety standards.
Use Cases
MindMaze technologies are primarily used for stroke rehabilitation, supporting both early and long-term recovery. In acute care, MindMotion™ PRO helps patients begin neurorehabilitation within days of a stroke, reducing the risk of long-term disability.
In traumatic brain injury (TBI) cases, MindMaze solutions help restore motor skills and cognitive function through tailored therapy modules. The immersive interface enhances engagement, especially in patients with limited motivation or attention deficits.
MindMaze platforms are also used in Parkinson’s disease management, where motor coordination and cognitive function decline progressively. The system helps patients maintain mobility, reduce fall risk, and manage disease progression with ongoing therapeutic exercises.
In home-based care, MindMotion™ GO enables remote rehabilitation by guiding patients through exercises without the need for in-person supervision. This is particularly beneficial for rural patients or those with mobility restrictions.
MindMaze is also involved in clinical trials and neurological research, supporting data collection for digital biomarkers and therapy outcomes across a wide spectrum of neurological conditions.
Pricing
MindMaze does not provide specific pricing details on its website. Pricing typically depends on the selected platform (MindMotion™ GO or PRO), deployment model (inpatient vs. home-based), volume of use, and required support services.
Healthcare institutions, clinics, and research centers are encouraged to contact MindMaze directly to receive a tailored quote and learn more about licensing, training, and technical support options.
MindMaze also collaborates with government healthcare systems and insurers for potential reimbursement models, depending on the country and health policy landscape.
Strengths
A key strength of MindMaze is its clinical-grade, AI-powered neurorehabilitation platform, which is designed to initiate therapy early and continue it throughout the recovery journey. The use of gamified VR experiences increases patient engagement and promotes adherence to rehabilitation programs.
MindMaze’s ability to integrate motor and cognitive therapy into one platform provides a comprehensive recovery solution, which is rare among other digital rehabilitation tools. The platform’s motion tracking precision and real-time feedback deliver measurable progress data that clinicians can act upon.
Another strength is its flexibility of deployment. The technology can be used across various healthcare environments, including hospitals, outpatient clinics, and home care, expanding its accessibility and impact.
MindMaze also benefits from strong clinical partnerships and validation studies, which support its effectiveness and establish it as a credible tool in both academic and commercial settings.
Drawbacks
One limitation is that MindMaze systems require specialized hardware and sensors, which could increase costs and necessitate training for clinical staff. Smaller clinics or under-resourced settings may find initial implementation challenging.
The absence of public pricing information may make it harder for institutions to evaluate cost-effectiveness without engaging in a formal consultation.
While VR-based therapy is highly engaging, some patients may experience motion sickness or fatigue, particularly older adults or those with cognitive impairments. These effects must be considered during long sessions.
MindMaze is a high-end solution that may not suit all patient profiles, particularly those who require only minimal rehabilitation or those unable to interact with digital systems due to severe impairments.
Comparison with Other Tools
MindMaze competes with other digital rehabilitation platforms like RehabVR, Reflexion Health, and Neofect. While many of these tools offer gamified or VR-based therapy, MindMaze differentiates itself through its integration of cognitive and motor training, and its strong clinical research foundation.
Compared to Reflexion Health, which focuses on physical therapy with motion capture, MindMaze adds cognitive rehabilitation layers and is backed by broader neurological research. Neofect, which offers gamified hand therapy, is more specialized, whereas MindMaze provides full-body motion and brain-based therapy.
MindMaze’s AI-driven personalization and acute care capabilities give it an edge for hospitals and research institutions looking for more than just rehabilitation games. It also offers early-intervention tools like MindMotion™ PRO, which many competitors lack.
Customer Reviews and Testimonials
MindMaze is used by top rehabilitation centers and hospitals globally. Though direct testimonials are limited on the website, case studies and publications show positive patient and clinician feedback regarding the platform’s usability and impact on recovery.
Clinicians report that the engaging nature of MindMaze therapy improves patient adherence, while the real-time feedback and measurable progress help them tailor interventions more effectively. Patients often describe the therapy as more enjoyable than traditional rehabilitation, which encourages continued participation.
The platform has received industry recognition and regulatory approvals across Europe and other regions, and it is involved in several international clinical trials assessing digital therapeutics in neurorehabilitation.
Conclusion
MindMaze is redefining neurorehabilitation through its AI-powered, immersive therapy platforms designed to enhance recovery for stroke, brain injury, and neurological disorders. By merging neuroscience, virtual reality, and motion tracking, the company delivers highly engaging and effective rehabilitation experiences that support both cognitive and motor recovery.
With solutions tailored for hospital, outpatient, and home environments, MindMaze offers scalable digital therapeutics that increase patient access, optimize therapy workflows, and improve outcomes. Its strong research foundation, early intervention focus, and comprehensive therapy approach position it as a leader in the next generation of neurotechnology.
Healthcare providers looking to elevate their neurorehabilitation programs with cutting-edge digital tools will find MindMaze to be a powerful and clinically validated partner. To learn more or schedule a demonstration, visit the official website at https://mindmaze.com.
